| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198901263200404 |
| P698 | PubMed publication ID | 2643047 |
| P2093 | author name string | Granfors K | |
| Merilahti-Palo R | |||
| Saario R | |||
| Toivanen A | |||
| Isomäki H | |||
| von Essen R | |||
| Jalkanen S | |||
| Pekkola-Heino K | |||
| Lahesmaa-Rantala R | |||
| Isomäki O | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 216-221 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Yersinia antigens in synovial-fluid cells from patients with reactive arthritis | |
| P478 | volume | 320 |
| Q33265731 | A Ribosomal Protein ofYersina PseudotuberculosisHaving Partial Epitope Identity with HLA-B27 |
| Q33566740 | Absence of Mycobacterium tuberculosis DNA in synovial fluid from patients with rheumatoid arthritis |
| Q28379037 | Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids |
| Q41506088 | Acute and chronic liver disease associated withYersinia enterocoliticainfection: a Norwegian 10-year follow-up study of 458 hospitalized patients |
| Q37885605 | Aetiological agents and immune mechanisms in enterogenic reactive arthritis |
| Q37879218 | Aetiological agents: their molecular biology and phagocyte-host interaction |
| Q33584099 | Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis |
| Q24817182 | Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27 |
| Q35729762 | Altered PKR Signalling and C / EBPβ Expression is Associated with HLA-B27 Expression in Monocytic Cells |
| Q34876252 | Altered regulation of ELAVL1/HuR in HLA-B27-expressing U937 monocytic cells |
| Q31117931 | An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis |
| Q54165668 | Ankylosing spondylitis |
| Q41509518 | Antibodies to arthritis-associated microbes in inflammatory joint diseases |
| Q45133671 | Antibodies to human cytomegalovirus 65-kilodalton Fc binding protein in rheumatoid arthritis: idiotypic mimicry hypothesis of rheumatoid factor production |
| Q36706366 | Antigenic Mimicry and Autoimmune Diseases |
| Q73417868 | Arthritis as the presenting symptom of diverticulitis |
| Q41640684 | Arthritis by autoreactive T cell lines obtained from rats after injection of intestinal bacterial cell wall fragments |
| Q35388769 | Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats |
| Q34261751 | Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid. |
| Q37804353 | Autoimmune thyroid diseases and enteropathogenic Yersinia enterocolitica |
| Q34212898 | Bacteria-Triggered reactive arthritis: implications for antibacterial treatment |
| Q37894845 | Bacterial antibodies in ankylosing spondylitis. |
| Q33563378 | Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis |
| Q35399143 | Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression. |
| Q35312007 | Bartonella henselae associated uveitis and HLA-B27. |
| Q54661660 | Binding of bacterial adhesins to rat glomerular mesangium in vivo. |
| Q38678809 | Bowel infection predisposing to reactive arthritis |
| Q49086643 | Bowel inflammation and the spondyloarthropathies |
| Q71803043 | Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis |
| Q34194217 | Cationic Yersinia antigen-induced chronic allergic arthritis in rats. A model for reactive arthritis in humans |
| Q35549024 | Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis |
| Q41488373 | Characterization of a superantigen produced by Yersinia pseudotuberculosis |
| Q33562876 | Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis |
| Q37391295 | Chlamydiae as pathogens--an overview of diagnostic techniques, clinical features, and therapy of human infections |
| Q37873826 | Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis |
| Q36589833 | Chronic Lyme Disease and Co-infections: Differential Diagnosis |
| Q41481501 | Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis |
| Q37365815 | Clinical role for a superantigen in Yersinia pseudotuberculosis infection |
| Q33567501 | Clinically silent infections in patients with oligoarthritis: results of a prospective study |
| Q36786554 | Colonization and impact of disease and other factors on intestinal microbiota. |
| Q42126037 | Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies |
| Q40672371 | Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later. |
| Q37230448 | Comparison of crossed immunoelectrophoresis, enzyme-linked immunosorbent assays, and tube agglutination for serodiagnosis of Yersinia enterocolitica serotype O:3 infection |
| Q41010908 | Course of gut inflammation in spondylarthropathies and therapeutic consequences |
| Q34001315 | Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat. |
| Q39823043 | Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis in rats |
| Q33564018 | Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence |
| Q33730521 | Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study |
| Q35688991 | Disease mechanisms in reactive arthritis |
| Q41244545 | Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis? |
| Q37846371 | Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis |
| Q36364308 | Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms |
| Q41439432 | ECA-immunogenicity of Proteus mirabilis strains |
| Q35553062 | Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis |
| Q38956178 | Effects of Yersinia enterocolitica O:3 derivatives on B lymphocyte activation in vivo |
| Q37804351 | Enhanced inflammatory reactivity in the pathogenesis of spondyloarthropathies. |
| Q36830824 | Enteropathic spondyloarthritis: from diagnosis to treatment. |
| Q67672055 | Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein |
| Q41507193 | Experimental Yersinia enterocolitica infection in rats: analysis of the immune response to plasmid-encoded antigens of arthritis-susceptible Lewis rats and arthritis-resistant Fischer rats |
| Q39824792 | Experimental Yersinia infection of human synovial cells: persistence of live bacteria and generation of bacterial antigen deposits including "ghosts," nucleic acid-free bacterial rods |
| Q41510092 | Expression cloning of Yersinia enterocolitica 0 : 3 rfb gene cluster in Escherichia coli K12 |
| Q37873521 | Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection |
| Q28344490 | Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with Pneumococcal meningitis |
| Q67467259 | Granzyme A — Immunoreactive cells in synovial fluid in reactive and rheumatoid arthritis |
| Q50107782 | HLA-B27 modulates nuclear factor kappaB activation in human monocytic cells exposed to lipopolysaccharide. |
| Q35556649 | HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. |
| Q24625587 | HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations |
| Q41107416 | HLA‐B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells |
| Q40830503 | Heat shock (stress) proteins and autoimmunity in rheumatic diseases |
| Q36924511 | Heat shock proteins and autoimmunity in humans |
| Q36970606 | Heat shock proteins in immunopathology |
| Q41489721 | High frequency of Yersinia antibodies in healthy populations in Finland and Germany |
| Q32115630 | Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis |
| Q34504976 | Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. |
| Q41488604 | Host-microbe interaction in HLA-B27-associated diseases |
| Q41609395 | Host-pathogen interactions in the immunopathogenesis of Lyme disease |
| Q68548833 | How does HLA-B27 confer susceptibility to inflammatory arthritis? |
| Q41489420 | Humoral immune response in Yersinia enterocolitica O:5 induced arthritis in hamsters |
| Q35210224 | Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreacti |
| Q40269220 | Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis |
| Q33578225 | IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis |
| Q37542520 | Immune functions and inflammatory reactions in HLA-B27 positive subjects |
| Q37885864 | Immunization of HLA-B27 transgenic and non transgenic mice with Salmonella typhimurium results predominantly in the generation of proliferative T cell responses |
| Q34015063 | Immunological basis of Chlamydia induced reactive arthritis |
| Q35550729 | Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha |
| Q72712070 | In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis |
| Q47973500 | Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection |
| Q58296571 | Infection and Arthritis |
| Q39523188 | Infection of synovial fibroblasts in culture by Yersinia enterocolitica and Salmonella enterica serovar Enteritidis: ultrastructural investigation with respect to the pathogenesis of reactive arthritis |
| Q35551114 | Infectious background of patients with a history of acute anterior uveitis |
| Q64266088 | Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment |
| Q34374516 | Insights into the Role of Infection in the Spondyloarthropathies |
| Q35694939 | Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis |
| Q40739135 | Intestinal symptoms and serological response in patients with complicated and uncomplicated Yersinia enterocolitica infections |
| Q40727524 | Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27. |
| Q24795821 | Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA |
| Q36745101 | Isolation of an R- M+ mutant of Yersinia enterocolitica serotype O:8 and its application in construction of rough mutants utilizing mini-Tn5 derivatives and lipopolysaccharide-specific phage |
| Q41508337 | Isolation ofYERSINIA-Specific T Cell Clones from the Synovial Membrane and Synovial Fluid of a Patient with Reactive Arthritis |
| Q37349737 | Joint expedition: linking gut inflammation to arthritis |
| Q41587392 | Juvenile-onset spondyloarthropathies |
| Q41447633 | Kinetics of B cell response during Yersinia enterocolitica infection in resistant and susceptible strains of mice |
| Q64124630 | Kinetics of serum antibodies in response to infection with Yersinia enterocolitica |
| Q38718467 | Leukocyte-endothelial cell interaction and the control of leukocyte migration into inflamed synovium |
| Q33564260 | Long term follow up of SHR rats with experimental yersinia associated arthritis |
| Q35547416 | Long-term prognosis of reactive salmonella arthritis |
| Q37953424 | Lymphocyte homing into the gut. |
| Q37893052 | MHC restriction of synovial fluid lymphocyte responses to the triggering organism in reactive arthritis. Absence of a class I-restricted response |
| Q41551463 | Management of osteoarthritis in cats |
| Q33645049 | Microarray Analysis of Response of Salmonella during Infection of HLA-B27- Transfected Human Macrophage-Like U937 Cells |
| Q43421917 | Microbe hunting in the joints |
| Q90165097 | Microbiota-mediated mucosal inflammation in arthritis |
| Q50124010 | Modulation of peripheral blood mononuclear cell activation status during Salmonella-triggered reactive arthritis |
| Q33581522 | Molecular mimicry--hypothesis or reality? |
| Q34000285 | Monocytes that have ingested Yersinia enterocolitica serotype O:3 acquire enhanced capacity to bind to nonstimulated vascular endothelial cells via P-selectin. |
| Q34118525 | Muramic acid is not generally present in the human spleen as determined by gas chromatography-tandem mass spectrometry |
| Q58136341 | New Views into the Pathogenesis of Reactive Arthritis |
| Q37878139 | No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study |
| Q35201237 | Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis |
| Q39769547 | Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats |
| Q41505970 | Oxygen radical production and trapping in subjects with previous Yersinia infection |
| Q77803173 | Pathogenesis of human leukocyte antigen B27-positive arthritis. Information from clinical materials |
| Q59487887 | Peripheral blood monocytes from patients with reactive arthritis show normal production of tumour necrosis factor-alpha |
| Q41486049 | Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis |
| Q34561991 | Phosphorylation of STAT-1 serine 727 is prolonged in HLA-B27-expressing human monocytic cells |
| Q41291478 | Polyarteritis associated with Yersinia enterocolitica infection |
| Q72153343 | Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis |
| Q41459389 | Production of autoantibodies associated with polyclonal activation in Yersinia enterocolitica O: 8-infected mice |
| Q37879332 | Prognosis, course of disease, and treatment of the spondyloarthropathies |
| Q41512504 | Proliferative response of synovial fluid and peripheral blood mononuclear cells to arthritogenic and non-arthritogenic microbial antigens and to the 65-kDa mycobacterial heat-shock protein |
| Q35418279 | Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers |
| Q32182055 | Reactive Arthritis Caused by Yersinia enterocolitica Enteritis |
| Q74600335 | Reactive arthritis |
| Q40830527 | Reactive arthritis associated with Clostridium difficile pseudomembranous colitis |
| Q73668560 | Reactive arthritis associated with prolonged cryptosporidial infection |
| Q36750290 | Reactive arthritis following Yersinia pseudotuberculosis infection. |
| Q34702169 | Reactive arthritis or chronic infectious arthritis? |
| Q37885274 | Reactive arthritis, diagnosis and treatment: a review |
| Q48024843 | Reactive arthritis-associated bacteria can stimulate lymphocyte proliferation in non-exposed individuals and newborns |
| Q35084874 | Reactive arthritis: newer developments |
| Q35838706 | Reactive arthritis: the role of bacterial antigens in inflammatory arthritis |
| Q35548336 | Reactive or infectious arthritis |
| Q41521245 | Recognition and Management of Bacterial Arthritis |
| Q77803152 | Reiter's syndrome. Diagnosis and clinical features |
| Q41259661 | Responses of synovial fluid and peripheral blood mononuclear cells to bacterial antigens and autologous antigen presenting cells |
| Q97530140 | Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q45267909 | Role of YadA in Yersinia-enterocolitica-induced reactive arthritis: a hypothesis |
| Q41671690 | Role of endogenous enteric organisms in the reactivation of arthritis |
| Q67655417 | Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis |
| Q50128628 | Salmonella typhimurium porin internalization by leukocytes |
| Q50466803 | Salmonella-reactive synovial fluid T-cell clones in a patient with post-infectious Salmonella arthritis. |
| Q74118322 | Septic arthritis |
| Q33962414 | Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis. |
| Q41010902 | Spondylarthropathies: from gut to target organs |
| Q37898139 | Synovial T lymphocyte recognition of organisms that trigger reactive arthritis |
| Q37623872 | Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation |
| Q37897015 | Synovial fluid antigen-presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis |
| Q41164543 | Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells |
| Q37387869 | Synoviocyte-packaged Chlamydia trachomatis induces a chronic aseptic arthritis |
| Q53023788 | T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis. |
| Q36956482 | T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica |
| Q36364212 | The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis |
| Q67898611 | The distribution and functional properties of dendritic cells in patients with seronegative arthritis |
| Q36437468 | The evolutionarily conserved ribosomal protein L23 and the cationic urease beta-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in Yersinia-triggered reactive arthritis: implications for autoimmunity |
| Q77936247 | The immunogenetics of the seronegative spondyloarthropathies |
| Q57291610 | The microbiome and HLA-B27-associated acute anterior uveitis |
| Q36783781 | The putative arthritogenic cationic 19-kilodalton antigen of Yersinia enterocolitica is a urease beta-subunit. |
| Q37890904 | The value of specific antibody detection and culture in the diagnosis of reactive arthritis |
| Q35554555 | Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study |
| Q36362491 | Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment |
| Q41482071 | Tumor necrosis factor receptor p55 controls the severity of arthritis in experimental Yersinia enterocolitica infection. |
| Q43548067 | Two color analysis of HLA-B27 antigen by flow cytometer--a comparative study by conventional microlymphocytotoxicity, DNA genotyping polymerase chain reaction and flow cytometric measurement |
| Q33782299 | Two forms of reactive arthritis? |
| Q38760986 | What can we learn about rheumatoid arthritis from animal models? |
| Q24683715 | Yersinia enterocolitica: the charisma continues |
| Q33617369 | Yersinia lipopolysaccharide is modified by human monocytes |
| Q33566566 | Yersinia-specific antibodies in serum and synovial fluid in patients with Yersinia triggered reactive arthritis |
| Q41449173 | Yersinia-triggered arthritis in IL-12p40-deficient mice: relevant antigens and local expression of Toll-like receptor mRNA. |
| Q56964364 | [Spondyloarthritis] |
Search more.